Temozolomide targets and arrests a doxorubicin-resistant follicular dendritic-cell sarcoma patient-derived orthotopic xenograft mouse model-Reference-Cited by-同舟云学术

Temozolomide targets and arrests a doxorubicin-resistant follicular dendritic-cell sarcoma patient-derived orthotopic xenograft mouse model

Published:2019-06 Issue: Volume:58 Page:17-23
ISSN:0040-8166
Container-title:Tissue and Cell
language:en
Short-container-title:Tissue and Cell

Author:

Oshiro Hiromichi,Tome Yasunori,Kiyuna Tasuku,Miyake Kentaro,Kawaguchi Kei,Higuchi Takashi,Miyake Masuyo,Zang Zhiying,Razmjooei Sahar,Barangi Maryam,Wangsiricharoen Sintawat,Nelson Scott D.,Li Yunfeng,Bouvet Michael,Singh Shree Ram,Kanaya Fuminori,Hoffman Robert M.

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,General Medicine

Reference73 articles.

1. Temozolomide induces senescence and repression of DNA repair pathways in glioblastoma cells via activation of ATR-CHK1, p21, and NF-κB;Aasland;Cancer Res.,2019

2. Follicular dendritic cell sarcoma: clinicopathologic study of 15 cases with emphasis on novel expression of MDM2, somatostatin receptor 2A, and PD-L1;Agaimy;Ann. Diagn. Pathol.,2016

3. Genomic analysis of follicular dendritic cell sarcoma by molecular inversion probe array reveals tumor suppressor-driven biology;Andersen;Mod. Pathol.,2017

4. CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications;Anderson;Am. J. Pathol.,2012

5. Imatinib in the treatment of follicular dendritic sarcoma: a case report and review of literature;Azim;Onkologie,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitors in Follicular Dendritic Cell Sarcoma;Immunotherapy;2024-02-16

2. Trabectedin and Lurbinectedin Modulate the Interplay between Cells in the Tumour Microenvironment—Progresses in Their Use in Combined Cancer Therapy;Molecules;2024-01-09

3. High Clinical Concordance of Drug Resistance in Patient-derived Orthotopic Xenograft (PDOX) Mouse Models: First Step to Validated Precise Individualized Cancer Chemotherapy;Anticancer Research;2023-09-29

4. Mouse Hematolymphoid Neoplasms;Pathology of Genetically Engineered and Other Mutant Mice;2021-12-16

5. Combination of CDK4/6 and mTOR Inhibitors Suppressed Doxorubicin-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model: A Translatable Strategy for Recalcitrant Disease;Anticancer Research;2021-07